NCT00887861View on ClinicalTrials.gov

Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
SeizuresEpilepsy
Interventions
DRUG

Investigational new drug, company code: BGG492

DRUG

Placebo

Trial Locations (6)

Unknown

Novartis Investigator Site, Berlin

Novartis Investigator Site, Bielefeld

Novartis Investigator Site, Bonn

Novartis Investigator Site, Erlangen

Novartis Investigator Site, Freiburg im Breisgau

Novartis Investigator Site, Munich

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY

NCT00887861 - Efficacy of BGG492 in Individuals With Refractory Partial Seizures Undergoing Inpatient Evaluation for Epilepsy Surgery | Biotech Hunter | Biotech Hunter